Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
From MaRDI portal
Publication:4602119
DOI10.5705/SS.202015.0174zbMATH Open1382.62059OpenAlexW2593820982MaRDI QIDQ4602119FDOQ4602119
Authors: Yunjian Yin, Zhi Geng, Fang Lu, Xiao-Hua Zhou
Publication date: 26 January 2018
Published in: STATISTICA SINICA (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.5705/ss.202015.0174
Recommendations
- Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
- Assessing the treatment effect heterogeneity with a latent variable
- Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
- Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
- Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints
Nonparametric estimation (62G05) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Cited In (5)
- Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
- Assessing the treatment effect heterogeneity with a latent variable
- Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
- Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
- A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime
This page was built for publication: Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4602119)